Lofiego, M.F.; Cannito, S.; Fazio, C.; Piazzini, F.; Cutaia, O.; Solmonese, L.; Marzani, F.; Chiarucci, C.; Di Giacomo, A.M.; Calabrò, L.;
et al. Epigenetic Immune Remodeling of Mesothelioma Cells: A New Strategy to Improve the Efficacy of Immunotherapy. Epigenomes 2021, 5, 27.
https://doi.org/10.3390/epigenomes5040027
AMA Style
Lofiego MF, Cannito S, Fazio C, Piazzini F, Cutaia O, Solmonese L, Marzani F, Chiarucci C, Di Giacomo AM, Calabrò L,
et al. Epigenetic Immune Remodeling of Mesothelioma Cells: A New Strategy to Improve the Efficacy of Immunotherapy. Epigenomes. 2021; 5(4):27.
https://doi.org/10.3390/epigenomes5040027
Chicago/Turabian Style
Lofiego, Maria Fortunata, Sara Cannito, Carolina Fazio, Francesca Piazzini, Ornella Cutaia, Laura Solmonese, Francesco Marzani, Carla Chiarucci, Anna Maria Di Giacomo, Luana Calabrò,
and et al. 2021. "Epigenetic Immune Remodeling of Mesothelioma Cells: A New Strategy to Improve the Efficacy of Immunotherapy" Epigenomes 5, no. 4: 27.
https://doi.org/10.3390/epigenomes5040027
APA Style
Lofiego, M. F., Cannito, S., Fazio, C., Piazzini, F., Cutaia, O., Solmonese, L., Marzani, F., Chiarucci, C., Di Giacomo, A. M., Calabrò, L., Coral, S., Maio, M., Covre, A., & on behalf of the EPigenetic Immune-Oncology Consortium Airc (EPICA) Investigators.
(2021). Epigenetic Immune Remodeling of Mesothelioma Cells: A New Strategy to Improve the Efficacy of Immunotherapy. Epigenomes, 5(4), 27.
https://doi.org/10.3390/epigenomes5040027